The researchers warned that while the data revealed into rosacea subtypes, their findings should be interpreted with caution due to a high degree of heterogeneity.
A systematic review of data from across the globe is characterizing the prevalence of 4 recognized subtypes of rosacea, which the researchers found varied based on gender, year of study publication, and the country the study was performed in.
Across the 9000 patients, erythematotelangiectatic (ETR) and papulopustular rosacea (PPR) were the most common subtypes of the condition, with a prevalence of 57% and 43%, respectively. The prevalence of phymatous rosacea (PhR) was 7% and the prevalence of ocular rosacea was 11%.
The researchers warned that while the data revealed into rosacea subtypes, their findings should be interpreted with caution due to a high degree of heterogeneity.
“Better and more detailed reporting is warranted in future studies to allow for new and improved insight into subtypes and their possible association with clinical characteristics and comorbidities,” emphasized the researchers. “We also strongly recommend that future studies use the phenotype-based approach to diagnose and report rosacea.”
The data, pulled from 39 studies, showed that the prevalence of subtypes was generally similar between genders, with the exception of PhR, which was more common among men. The researchers noted that they were not able to explore gender trends for ocular rosacea.
ETR was more common in general population studies while PPR was more common in clinical population studies. According to the researchers, the finding suggests that patients are more likely to seek medical help for PPR, which has been associated with slightly poorer quality of life compared with ETR.
“Data suggested that the proportion of patients with PPR was higher in studies with older publication dates, whereas the proportion of patients with ETR was higher in more recent publications,” wrote the researchers. “This may be explained by a change in environmental exposures leading to certain rosacea subtypes, better or earlier interventions to treat PPR, or increased awareness of rosacea; or it may be a random finding. Also, the increase in ETR could reflect overall increased numbers of patients with rosacea due to change in lifestyle, such as increased intake of alcohol and spicy food, increased UV exposure, or perhaps increased access to laser treatments.”
Across the included studies were populations of patients from different countries, which revealed differences in the presence of rosacea subtypes. Patients from Africa exhibited lower rates of ETR, which the researchers explained could be due to the patients having darker skin, making it harder to diagnose the subtype, or due to these patients not wanting to seek medical help because the burden of the condition is less severe than for patients with lighter skin.
Reference
Barakji Y, Rønnstad A, Christensen M, Zachariae C, et al. Assessment of frequency of rosacea subtypes in patients with rosacea: A systematic review and meta-analysis. JAMA Dermatol. Published online April 6, 2022. doi:10.1001/jamadermatol.2022.0526
Patients With Actinic Keratosis Prefer Simulated Daylight PDT Over More Painful Red Light PDT
April 22nd 2024A recent study found that patients with actinic keratosis experienced more pain during red light photodynamic therapy (PDT) than simulated daylight PDT, emphasizing the need to understand patient experiences for better treatment decisions.
Read More
Secukinumab Proves Successful in Treating Severe HS, Safety Persists at Week 52
April 11th 2024In a recent study, secukinumab therapy demonstrated adequate safety and efficacy profiles, offering potential benefits for patients with severe hidradenitis suppurativa (HS) who found adalimumab intolerable.
Read More
Delays in HS Diagnosis, Treatment Shed Light on Provider Education Gaps
April 5th 2024Patients with hidradenitis suppurativa (HS) in Canada often wait long periods of time to receive an HS diagnosis and receive evidence-based therapy, highlighting the need for increased interdisciplinary education on HS management.
Read More
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
AI Dermatology Mobile Apps Have Critical Efficacy, Safety Gaps, Review Says
March 17th 2024This scoping review discovered potential risks and critical gaps in the efficacy, safety, and transparency of current artificial intelligence (AI) dermatology mobile apps, emphasizing the need for regulatory intervention.
Read More